Re-envisioning genetic predisposition to childhood and adolescent cancers
- 3 December 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 25 (2) , 109-128
Abstract
Although cancer is rare in children and adolescents, it remains a leading cause of death within this age range, and genetic predisposition is the main known risk factor. Since the discovery of retinoblastoma-predisposing RB1 pathogenic germline variants in 1985, several additional high-penetrance cancer predisposition genes (CPGs) have been identified. Although few clinically recognizable genetic conditions display moderate cancer phenotypes, burden testing has revealed low-to-moderate penetrance CPGs. In addition to germline pathogenic variants in CPGs, postzygotic somatic mosaic CPG pathogenic variants acquired during embryonic development are increasingly recognized as factors that predispose children and adolescents to malignancies. Genome-wide association studies of various childhood and adolescent cancer types have identified some common low-risk cancer susceptibility alleles. Although the clinical utility of polygenic risk scores is currently limited in children and adolescents, polygenic risk scores developed for adults can predict subsequent cancer risks in childhood and adolescent cancer survivors. In this Review, I describe our current knowledge of genetic predisposition to childhood and adolescent cancers. Survival rates in children and adolescents with cancer and CPGs are often poor, necessitating better integration of genomic testing into clinical care to improve cancer prevention, surveillance and therapies.Keywords
This publication has 256 references indexed in Scilit:
- Germline Genetic Testing and Survival Outcomes Among Children With RhabdomyosarcomaJAMA Network Open, 2024
- Management of Down Syndrome–Associated LeukemiasJAMA Oncology, 2023
- Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data SetJAMA Oncology, 2021
- A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and PhenotypeJAMA Network Open, 2021
- Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non–Hodgkin LymphomaJAMA Oncology, 2019
- Solid tumor screening recommendations in trisomy 18American Journal of Medical Genetics Part A, 2019
- Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutationAmerican Journal of Medical Genetics Part A, 2016
- Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalitiesAmerican Journal of Medical Genetics Part A, 2015
- Perlman syndrome: Report, prenatal findings and reviewAmerican Journal of Medical Genetics Part A, 2008
- New finding of Schinzel‐Giedion syndrome: A case with a malignant sacrococcygeal teratomaAmerican Journal of Medical Genetics, 1993